Evaluation of Immunologic Parameters in Canine Glioma Patients Treated with an Oncolytic Herpes Virus

被引：0
|
作者：
Estevez-Ordonez, Dagoberto
Chambers, Melissa
Foote, Jeremy
Bentley, R. Timothy
Botta, Davide
Crossman, David
Della Manna, Deborah
Koehler, Jey
Langford, Catherine
Miller, Margaret
Markert, James [1 ]
Oliver, Alicia
Omar, Nidal [1 ]
Platt, Simon
Rissi, Daniel
Shores, Andy
Sorjonen, Donald
Yang, Eddy
Yanke, Amy
Gillespie, Yancey [1 ]
机构：
[1] Univ Alabama Birmingham, Neurosurg, Birmingham, AL USA
来源：
JOURNAL OF NEUROSURGERY | 2022年 / 136卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
454
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Human Glioblastoma-Derived Cancer Stem Cells: Establishment of Invasive Glioma Models and Treatment with Oncolytic Herpes Simplex Virus Vectors
    Wakimoto, Hiroaki
    Kesari, Santosh
    Farrell, Christopher J.
    Curry, William T., Jr.
    Zaupa, Cecile
    Aghi, Manish
    Kuroda, Toshihiko
    Stemmer-Rachamimov, Anat
    Shah, Khalid
    Liu, Ta-Chiang
    Jeyaretna, Deva S.
    Debasitis, Jason
    Pruszak, Jan
    Martuza, Robert L.
    Rabkin, Samuel D.
    CANCER RESEARCH, 2009, 69 (08) : 3472 - 3481
  • [42] Evaluating the effects of oncolytic Herpes Simplex Virus (SEPREHVIR) on paediatric high grade glioma viability, migration and invasion; Potential for clinical application
    Cockle, Julia V.
    Ilett, Elizabeth
    Scott, Karen
    Bruening-Richardson, Anke
    Picton, Susan
    Short, Susan
    Melcher, Alan
    HUMAN GENE THERAPY, 2014, 25 (12) : A26 - A27
  • [43] IL-12 Expressing oncolytic herpes simplex virus promotes anti-tumor activity and immunologic control of metastatic ovarian cancer in mice
    Eric D. Thomas
    Selene Meza-Perez
    Kerri S Bevis
    Troy D. Randall
    G. Yancey Gillespie
    Catherine Langford
    Ronald D. Alvarez
    Journal of Ovarian Research, 9
  • [44] RESULTS OF PHASE II CLINICAL TRIAL OF ONCOLYTIC HERPES VIRUS G47Δ IN PATIENTS WITH GLIOBLASTOMA
    Todo, Tomoki
    NEURO-ONCOLOGY, 2019, 21 : 4 - 4
  • [45] IL-12 Expressing oncolytic herpes simplex virus promotes anti-tumor activity and immunologic control of metastatic ovarian cancer in mice
    Thomas, Eric D.
    Meza-Perez, Selene
    Bevis, Kerri S.
    Randall, Troy D.
    Gillespie, G. Yancey
    Langford, Catherine
    Alvarez, Ronald D.
    JOURNAL OF OVARIAN RESEARCH, 2016, 9 : 1 - 11
  • [46] An oncolytic adenovirus expressing herpes simplex virus-thymidine kinase for targeting cancer therapy: An in vitro evaluation
    Zheng, Fei-qun
    Xu, Yin
    Qin, Yi-de
    Yang, Ren-jie
    Han, Jun
    CHINESE JOURNAL OF CANCER RESEARCH, 2009, 21 (02) : 90 - 96
  • [47] Preclinical safety and biodistribution evaluation of an oncolytic herpes simplex virus type I armed with interleukin-12
    Iwai, Miwako
    Ino, Yasushi
    Fukuhara, Hiroshi
    Todo, Tomoki
    CANCER SCIENCE, 2018, 109 : 965 - 965
  • [48] An Oncolytic Adenovirus Expressing Herpes Simplex Virus-Thymidine Kinase for Targeting Cancer Therapy:An in vitro Evaluation
    Fei-qun Zheng1
    ChineseJournalofCancerResearch, 2009, 21 (02) : 90 - 96
  • [49] Toxicity evaluation of replication-competent herpes simplex virus (ICP 34.5 null mutant 1716) in patients with recurrent malignant glioma
    R Rampling
    G Cruickshank
    V Papanastassiou
    J Nicoll
    D Hadley
    D Brennan
    R Petty
    A MacLean
    J Harland
    E McKie
    R Mabbs
    M Brown
    Gene Therapy, 2000, 7 : 859 - 866
  • [50] Toxicity evaluation of replication-competent herpes simplex virus (ICP 34.5 null mutant 1716) in patients with recurrent malignant glioma
    Rampling, R
    Cruickshank, G
    Papanastassiou, V
    Nicoll, J
    Hadley, D
    Brennan, D
    Petty, R
    MacLean, A
    Harland, J
    McKie, E
    Mabbs, R
    Brown, M
    GENE THERAPY, 2000, 7 (10) : 859 - 866
12345